Live Market Updates
Latest Financial News
News Feed
1 articles
Personalized
Live Market Updates
Latest Financial News
positive
1 day agoMedline files for U.S. IPO targeting up to $50 billion valuation
Medline Industries has publicly filed for a U.S. initial public offering that could value the medical‐supplies giant at up to $50 billion. The company reported revenue of $13.53 billion in the first half of 2025—a 9.7% increase—alongside a profit of $655 million. Backed by private‐equity firms Blackstone, Carlyle Group and Hellman & Friedman, Medline’s listing is being seen as a key test of investor appetite across large U.S. IPOs after years of dormancy.
positive
1 day agoMedline files for U.S. IPO targeting up to $50 billion valuation
Medline Industries has publicly filed for a U.S. initial public offering that could value the medical‐supplies giant at up to $50 billion. The company reported revenue of $13.53 billion in the first half of 2025—a 9.7% increase—alongside a profit of $655 million. Backed by private‐equity firms Blackstone, Carlyle Group and Hellman & Friedman, Medline’s listing is being seen as a key test of investor appetite across large U.S. IPOs after years of dormancy.
positive
Medline files for U.S. IPO targeting up to $50 billion valuation
1 day ago
1 min read
73 words
Medline files for IPO with up to $50 billion valuation as investor appetite returns to major U.S. listings.
Medline Industries has publicly filed for a U.S. initial public offering that could value the medical‐supplies giant at up to $50 billion. The company reported revenue of $13.53 billion in the first half of 2025—a 9.7% increase—alongside a profit of $655 million. Backed by private‐equity firms Blackstone, Carlyle Group and Hellman & Friedman, Medline’s listing is being seen as a key test of investor appetite across large U.S. IPOs after years of dormancy.
Medline Industries has publicly filed for a U.S. initial public offering that could value the medical‐supplies giant at up to $50 billion. The company reported revenue of $13.53 billion in the first half of 2025—a 9.7% increase—alongside a profit of $655 million. Backed by private‐equity firms Blackstone, Carlyle Group and Hellman & Friedman, Medline’s listing is being seen as a key test of investor appetite across large U.S. IPOs after years of dormancy.
Tags:
ipo
markets
ipo
markets
US
healthcare
listing
Oct 28, 2025 • 22:55 IST